Cure8 trial brief
Researchers are investigating whether a specific gut bacterium (Pilosibacter rotomagensis) is linked to lower intestinal inflammation after surgery for ileal Crohn's disease. If true, this could point toward new microbiome-based strategies to prevent postoperative recurrence.
Adult patients with ileal Crohn's disease who have had ileocecal resection, clinicians who manage postoperative Crohn's disease, microbiome researchers, and investigators planning interventional prevention trials.
The study is single-center, cross-sectional, and not yet recruiting; it plans to enroll adults who had ileocecal resection for isolated ileal Crohn's disease. Investigators will measure fecal calprotectin (a noninvasive marker of intestinal inflammation) and analyze stool for P. rotomagensis carriage and short-chain fatty acids.
The design focuses on association, not causation, and will adjust for factors such as smoking, complicated disease phenotype (fistulizing or stenosing), and time since surgery.
If the study finds a protective association, authors say it could support larger multicenter longitudinal studies and eventually interventional trials testing oral supplementation with the bacterium. Until such trials are done, this record reports planned research rather than clinical evidence supporting any treatment.
This is an observational, cross-sectional study (not yet recruiting) designed to detect associations, not to prove causality. The protocol uses fecal calprotectin and stool microbiota analysis; any future clinical recommendations would require longitudinal and interventional validation.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study tests whether adding MRI-based transmural assessment to a fecal-calprotectin–guided (CALM) strategy improves the ability to keep people with Crohn’s disease in corticosteroid-free clinical remission and may...
After bowel resection, Crohn’s often returns quietly at the surgical join (anastomosis). Early, planned monitoring can detect inflammation before symptoms appear and help prevent symptomatic recurrence or repeat surgery.
Postoperative endoscopic recurrence after ileocolic resection is an important risk for people with Crohn’s disease; this study links HNBT and possibly e-cigarette use to higher recurrence rates, which could affect...
